ResMed Inc.

ResMed Inc. is a global medical equipment company that develops, manufactures, and distributes cloud-connectable medical devices and software solutions. Headquartered in San Diego, California, the company's core business revolves around addressing sleep-disordered breathing, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. ResMed's mission is to create life-changing health technologies that empower millions to live healthier lives, aiming to change 250 million lives by 2025 through its focus on global health epidemics and out-of-hospital care.

The company's key offerings fall into two principal business segments: Sleep and Respiratory Care, and Software as a Service (SaaS). Its product portfolio includes CPAP machines, masks, ventilators, and various digital health solutions designed to improve breathing and quality of life. ResMed also provides software platforms for out-of-hospital care agencies, facilitating care transitions for seniors and enabling remote patient monitoring through its cloud-connected devices. The company operates in over 140 countries worldwide.

Michael "Mick" Farrell has served as ResMed's CEO since March 2013. In recent news, ResMed completed the acquisition of Noctrix Health in June 2026, expanding its clinical sleep health portfolio with Nidra TOMAC therapy for Restless Legs Syndrome. The company also appointed Aaron Bloomer as its new CFO in April 2026, succeeding Brett Sandercock. ResMed reported strong third-quarter fiscal year 2026 financial growth, with revenue increasing by 11%. CEO Mick Farrell highlighted the company's innovations in AI for personalized sleep experiences and the impact of GLP-1 therapies on sleep apnea diagnosis. Despite a recent downgrade by Morgan Stanley in June 2026 due to potential GLP-1 drug headwinds and the possible market return of a competitor, ResMed maintains a strong market position as a global leader in connected health solutions for sleep and respiratory care.